Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000923450 | SCV001068927 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004857741 | SCV005501500 | uncertain significance | not specified | 2024-06-26 | criteria provided, single submitter | clinical testing | The c.4196C>T (p.P1399L) alteration is located in exon 15 (coding exon 13) of the SIPA1L3 gene. This alteration results from a C to T substitution at nucleotide position 4196, causing the proline (P) at amino acid position 1399 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |